These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 8577769)
1. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites. van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769 [TBL] [Abstract][Full Text] [Related]
2. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides. van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991 [TBL] [Abstract][Full Text] [Related]
3. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site. van der Geer P; Wiley S; Pawson T Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378 [TBL] [Abstract][Full Text] [Related]
4. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain. O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109 [TBL] [Abstract][Full Text] [Related]
6. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain. Dikic I; Batzer AG; Blaikie P; Obermeier A; Ullrich A; Schlessinger J; Margolis B J Biol Chem; 1995 Jun; 270(25):15125-9. PubMed ID: 7541035 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the phosphotyrosine-binding domain of the Drosophila Shc protein. Li SC; Lai KM; Gish GD; Parris WE; van der Geer P; Forman-Kay J; Pawson T J Biol Chem; 1996 Dec; 271(50):31855-62. PubMed ID: 8943228 [TBL] [Abstract][Full Text] [Related]
8. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation. Blaikie PA; Fournier E; Dilworth SM; Birnbaum D; Borg JP; Margolis B J Biol Chem; 1997 Aug; 272(33):20671-7. PubMed ID: 9252386 [TBL] [Abstract][Full Text] [Related]
9. Identification of residues within the SHC phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction. Yajnik V; Blaikie P; Bork P; Margolis B J Biol Chem; 1996 Jan; 271(4):1813-6. PubMed ID: 8567619 [TBL] [Abstract][Full Text] [Related]
10. Thermodynamic studies of SHC phosphotyrosine interaction domain recognition of the NPXpY motif. Mandiyan V; O'Brien R; Zhou M; Margolis B; Lemmon MA; Sturtevant JM; Schlessinger J J Biol Chem; 1996 Mar; 271(9):4770-5. PubMed ID: 8617744 [TBL] [Abstract][Full Text] [Related]
11. Phosphotyrosine binding domains of Shc and insulin receptor substrate 1 recognize the NPXpY motif in a thermodynamically distinct manner. Farooq A; Plotnikova O; Zeng L; Zhou MM J Biol Chem; 1999 Mar; 274(10):6114-21. PubMed ID: 10037694 [TBL] [Abstract][Full Text] [Related]
12. A Drosophila shc gene product is implicated in signaling by the DER receptor tyrosine kinase. Lai KM; Olivier JP; Gish GD; Henkemeyer M; McGlade J; Pawson T Mol Cell Biol; 1995 Sep; 15(9):4810-8. PubMed ID: 7651398 [TBL] [Abstract][Full Text] [Related]
13. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking. Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245 [TBL] [Abstract][Full Text] [Related]
14. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions. van der Geer P; Wiley S; Gish GD; Pawson T Curr Biol; 1996 Nov; 6(11):1435-44. PubMed ID: 8939605 [TBL] [Abstract][Full Text] [Related]
15. Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Zhou MM; Ravichandran KS; Olejniczak EF; Petros AM; Meadows RP; Sattler M; Harlan JE; Wade WS; Burakoff SJ; Fesik SW Nature; 1995 Dec; 378(6557):584-92. PubMed ID: 8524391 [TBL] [Abstract][Full Text] [Related]
16. PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities. Wolf G; Trüb T; Ottinger E; Groninga L; Lynch A; White MF; Miyazaki M; Lee J; Shoelson SE J Biol Chem; 1995 Nov; 270(46):27407-10. PubMed ID: 7499194 [TBL] [Abstract][Full Text] [Related]
17. Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules. Nakamura T; Komiya M; Gotoh N; Koizumi S; Shibuya M; Mori N Oncogene; 2002 Jan; 21(1):22-31. PubMed ID: 11791173 [TBL] [Abstract][Full Text] [Related]
18. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor. O'Bryan JP; Lambert QT; Der CJ J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397 [TBL] [Abstract][Full Text] [Related]
19. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo. Isakoff SJ; Yu YP; Su YC; Blaikie P; Yajnik V; Rose E; Weidner KM; Sachs M; Margolis B; Skolnik EY J Biol Chem; 1996 Feb; 271(8):3959-62. PubMed ID: 8626723 [TBL] [Abstract][Full Text] [Related]
20. Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine. Trüb T; Choi WE; Wolf G; Ottinger E; Chen Y; Weiss M; Shoelson SE J Biol Chem; 1995 Aug; 270(31):18205-8. PubMed ID: 7543098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]